Market updates, summit announcements and investment intelligence from the UK medical cannabis sector. Verified sources only. Updated regularly.
The UK medical cannabis market is approaching a £1 billion annual valuation and is expected to support 100,000 patients in 2026, according to industry analysis reported by LBC following a visit to Glass Pharms — one of the UK's largest Home Office-licensed cannabis cultivation facilities, located in Wiltshire.
Read at LBC →Mamedica — one of the UK's leading medical cannabis clinics with over 15,000 patients treated — was ranked number 8 in the Sunday Times 100 list of the fastest-growing private companies in the UK in 2026, validating the commercial momentum behind the UK's medical cannabis clinic sector and the growing interest of institutional capital in the space.
Read at Sunday Times →Germany's medical cannabis market — now the largest in Europe — reached an estimated €670 million in annual value in 2025, with over 100,000 patients receiving cannabis under Germany's statutory health insurance reimbursement system. The European medical cannabis market is projected to reach €2–4 billion by 2028 — providing a clear benchmark for UK market trajectory.
Read at Cannabis Europa →Subscribe to receive UK medical cannabis investment news and summit updates directly.
Subscribe for Updates →All news published by UKMC Events is sourced from verified primary sources — press releases from licensed companies, peer-reviewed research, regulatory announcements from the MHRA and Home Office, parliamentary records and statements from law enforcement bodies including the NPCC.
UKMC Events does not publish unverified claims, promotional content disguised as news, or any content that could reasonably mislead verified medical cannabis patients about the legal position of their prescription. The UK medical cannabis market is an area where misinformation carries real consequences — for patients who may act on incorrect legal guidance, and for investors who may make allocation decisions on the basis of inaccurate market data.
UKMC Events maintains editorial independence from all commercial relationships. No advertiser, sponsor or partner influences the editorial content of news published on this page. If you are aware of a significant UK medical cannabis investment development that should be covered, contact us at info@ukmcgroup.co.uk with verified source information.
UKMC Events · Part of UKMC Group Ltd · info@ukmcgroup.co.uk